Ajanta Pharma posted its sharpest fall in six months with no confirmed trigger. Here are the numbers, valuation and risks.

Aurobindo’s US arm launched ADQUEY ointment, entering the dermatology market. Here is what the product does, the levels and the risks.

Nifty Pharma is the best-performing index today as tariff clarity lifts Abbott, Mankind Pharma and Dr Reddy’s. Here is why, the levels and the risks.

Zydus Lifesciences drew one USFDA observation at its Ahmedabad plant, a day after a clean check elsewhere. Here is what it means and the risks.

Morepen filed its first US ANDA for Sitagliptin and the stock rose 2.5%. Here is what it means, the CDMO order behind the rally and the risks.

Zydus Lifesciences got nil observations from a USFDA pharmacovigilance inspection and hit a fresh high. Here is what it does and does not mean.

Lupin got tentative US FDA approval for a liquid apixaban, but the stock is lower with the market. Here are the levels, Q1 numbers and risks.

Sun Pharma signed an exclusive deal for lerodalcibep, a once-monthly cholesterol drug approved in the EU, with rights outside the US and China.

Unichem received five procedural USFDA observations at its Goa plant; the stock dipped 3.78 percent to Rs 529.40 and then recovered to near Rs 549.